<unk>  is a HIV-1 fusion inhibitor that is FDA approved for the treatment of HIV-1 infection in treatment-experienced patients with HIV-1 replication despite ongoing antiretroviral therapy.   Common adverse reactions include local injection site reactions, diarrhea, nausea, and fatigue.
Enfuvirtide
Saquinavir
Abacavir
Fosamprenavir
Entecavir
Remdesivir
Telaprevir
Tipranavir